Congenital chromosomal disease
|
0.010 |
Biomarker
|
group |
BEFREE |
RGS22 is a novel testis specific gene.It is located within chromosome 8q22.2, which shows high relevance with tumor chromosomal aberrations.
|
21533872 |
2011 |
Tumor Cell Invasion
|
0.020 |
AlteredExpression
|
phenotype |
BEFREE |
RGS22 is over-expressed in low metastatic epithelial cancers and involved in the processes of cell migration and invasion in esophageal cancer cell lines.
|
21533872 |
2011 |
Esophageal Neoplasms
|
0.010 |
AlteredExpression
|
group |
BEFREE |
RGS22 is over-expressed in low metastatic epithelial cancers and involved in the processes of cell migration and invasion in esophageal cancer cell lines.
|
21533872 |
2011 |
Esophageal carcinoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
RGS22 is over-expressed in low metastatic epithelial cancers and involved in the processes of cell migration and invasion in esophageal cancer cell lines.
|
21533872 |
2011 |
Malignant neoplasm of esophagus
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
RGS22 is over-expressed in low metastatic epithelial cancers and involved in the processes of cell migration and invasion in esophageal cancer cell lines.
|
21533872 |
2011 |
Basal cell carcinoma
|
0.100 |
GeneticVariation
|
disease |
GWASCAT |
Combined analysis of keratinocyte cancers identifies novel genome-wide loci.
|
31174203 |
2019 |
Basal Cell Neoplasm
|
0.100 |
GeneticVariation
|
disease |
GWASCAT |
Combined analysis of keratinocyte cancers identifies novel genome-wide loci.
|
31174203 |
2019 |
Basal Cell Cancer
|
0.100 |
GeneticVariation
|
disease |
GWASCAT |
Combined analysis of keratinocyte cancers identifies novel genome-wide loci.
|
31174203 |
2019 |
Basal cell carcinoma
|
0.100 |
GeneticVariation
|
disease |
GWASCAT |
Genome-wide association study identifies 14 novel risk alleles associated with basal cell carcinoma.
|
27539887 |
2016 |
Basal Cell Neoplasm
|
0.100 |
GeneticVariation
|
disease |
GWASCAT |
Genome-wide association study identifies 14 novel risk alleles associated with basal cell carcinoma.
|
27539887 |
2016 |
Basal Cell Cancer
|
0.100 |
GeneticVariation
|
disease |
GWASCAT |
Genome-wide association study identifies 14 novel risk alleles associated with basal cell carcinoma.
|
27539887 |
2016 |
Carcinoma, Basal Cell
|
0.110 |
GeneticVariation
|
disease |
GWASDB |
Germline sequence variants in TGM3 and RGS22 confer risk of basal cell carcinoma.
|
24403052 |
2014 |
Basal cell carcinoma
|
0.100 |
GeneticVariation
|
disease |
GWASCAT |
Germline sequence variants in TGM3 and RGS22 confer risk of basal cell carcinoma.
|
24403052 |
2014 |
Basal Cell Neoplasm
|
0.100 |
GeneticVariation
|
disease |
GWASCAT |
Germline sequence variants in TGM3 and RGS22 confer risk of basal cell carcinoma.
|
24403052 |
2014 |
Basal Cell Cancer
|
0.100 |
GeneticVariation
|
disease |
GWASCAT |
Germline sequence variants in TGM3 and RGS22 confer risk of basal cell carcinoma.
|
24403052 |
2014 |
Disseminated Malignant Neoplasm
|
0.010 |
AlteredExpression
|
phenotype |
BEFREE |
In addition, we examined the role of RGS22 over-expression in the processes of invasion and metastasis using a highly metastatic cancer cell line.
|
21533872 |
2011 |
Secondary Neoplasm
|
0.010 |
AlteredExpression
|
group |
BEFREE |
In addition, we examined the role of RGS22 over-expression in the processes of invasion and metastasis using a highly metastatic cancer cell line.
|
21533872 |
2011 |
Asthma
|
0.100 |
GeneticVariation
|
disease |
GWASDB |
Meta-analysis of genome-wide association studies of asthma in ethnically diverse North American populations.
|
21804549 |
2011 |
Basal cell carcinoma
|
0.100 |
GeneticVariation
|
disease |
GWASCAT |
New basal cell carcinoma susceptibility loci.
|
25855136 |
2015 |
Basal Cell Neoplasm
|
0.100 |
GeneticVariation
|
disease |
GWASCAT |
New basal cell carcinoma susceptibility loci.
|
25855136 |
2015 |
Basal Cell Cancer
|
0.100 |
GeneticVariation
|
disease |
GWASCAT |
New basal cell carcinoma susceptibility loci.
|
25855136 |
2015 |
stage IV esophageal cancer
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Over-expression of RGS22 in a highly metastatic esophageal cancer cell line causes decrease in cell migration and reduction in the invasive potential of the cells.
|
21533872 |
2011 |
Liver carcinoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
The new identified miR-1260b/RGS22 axis provides useful therapeutic methods for treatment of HCC deepening on our understanding of underlying mechanisms of HCC tumorigenesis.
|
29038925 |
2018 |
Carcinogenesis
|
0.020 |
Biomarker
|
phenotype |
BEFREE |
The new identified miR-1260b/RGS22 axis provides useful therapeutic methods for treatment of HCC deepening on our understanding of underlying mechanisms of HCC tumorigenesis.
|
29038925 |
2018 |
Neoplasms
|
0.010 |
Biomarker
|
group |
BEFREE |
Therefore, RGS22 may be an important tumor suppressor gene in tumorigenesis, a potential new diagnostic and prognostic biomarker for metastasis and may translate to therapeutic opportunities for the preventive treatment of epithelial cancer metastasis.
|
21533872 |
2011 |